Graft Programmed Death Ligand 1 Expression as a Marker for Transplant Rejection Following Anti-Programmed Death 1 Immunotherapy for Recurrent Liver Tumors.
作者信息
Shi Guo-Ming, Wang Jiping, Huang Xiao-Wu, Huang Xiao-Yong, He Yi-Feng, Ji Yuan, Chen Yi, Wu Dong, Lu Jia-Cheng, Sun Qi-Man, Liu Wei-Ren, Wang Ting, Yang Liu-Xiao, Hou Ying-Yong, Shi Ying-Hong, Sun Jian, Xiao Yong-Sheng, Wang Zheng, Fan Jia, Bertagnolli Monica M, Zhou Jian
机构信息
Department of Liver Surgery & TransplantationLiver Cancer Institute, Zhongshan Hospital, Fudan UniversityShanghaiChina.
Key Laboratory of Carcinogenesis and Cancer InvasionMinistry of Education of the People's Republic of ChinaShanghaiChina.
出版信息
Liver Transpl. 2021 Feb;27(3):444-449. doi: 10.1002/lt.25887. Epub 2020 Dec 5.
DOI:10.1002/lt.25887
PMID:32897657
Abstract
摘要
Zotero 插件